Geoff Bennett: The number of Americans taking GLP-1 drugs for weight loss is rising sharply. A new Gallup poll finds 11 percent of adults say they’re currently using one of the medications, up from just 3 percent two years ago. And that number could climb even higher now that Medicare has cleared the way for some patients to access these drugs, which can help reduce obesity substantially and the risk of other health problems. Our William Brangham […]

SUMMARY The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago when just 3% said they were using them. That number could climb even higher as Medicare has cleared the way for some patients to access the drugs. View the transcript of the story. NOTE: If you are short on […]

Published July 16, 2026 This is a summary of a story written by Shantell Kirkendoll on Duke University School of Medicine. Weight loss surgery has transformed lives for decades. Now, blockbuster GLP-1 drugs are accelerating that transformation and bringing a new challenge for plastic surgeons. New research from Duke University School of Medicine suggests that rapid weight loss, particularly when bariatric surgery is paired with GLP-1 medications, may increase risk of complications during body contouring procedures such […]

(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generation weight-loss drug, retatrutide, following positive results from two late-stage clinical trials. The drugmaker had previously indicated it could submit an application as early as 2026 for the weekly injectable treatment. According to Lilly, retatrutide works differently from other weight-loss medications currently on the market. In two Phase 3 trials, retatrutide produced significant weight loss and improvements in blood sugar […]